Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Equity Bancshares Inc is a banks-regional business based in the US. Equity Bancshares shares (EQBK) are listed on the NASDAQ and all prices are listed in US Dollars. Equity Bancshares employs 702 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
| Latest market close | $29.35 |
|---|---|
| 52-week range | $27.74 - $35.73 |
| 50-day moving average | $31.29 |
| 200-day moving average | $32.53 |
| Wall St. target price | $36.60 |
| PE ratio | 8.8323 |
| Dividend yield | $0.24 (1.1%) |
| Earnings per share (TTM) | $3.34 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $29.35 from 2022-07-05
| 1 week (2022-06-29) | 0.51% |
|---|---|
| 1 month (2022-06-07) | -9.72% |
| 3 months (2022-04-07) | -3.20% |
| 6 months (2022-01-07) | -15.44% |
| 1 year (2021-07-07) | 0.03% |
|---|---|
| 2 years (2020-07-07) | 90.34% |
| 3 years (2019-07-05) | 4.82% |
| 5 years (2017-07-06) | 31.55 |
Valuing Equity Bancshares stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Equity Bancshares's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Equity Bancshares's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Equity Bancshares shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
| Revenue TTM | $187.8 million |
|---|---|
| Operating margin TTM | 41.99% |
| Gross profit TTM | $183.3 million |
| Return on assets TTM | 1.14% |
| Return on equity TTM | 12.49% |
| Profit margin | 28.25% |
| Book value | $27.47 |
| Market capitalisation | $480.2 million |
TTM: trailing 12 months
Dividend payout ratio: 9.08% of net profits
Recently Equity Bancshares has paid out, on average, around 9.08% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.1% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Equity Bancshares shareholders could enjoy a 1.1% return on their shares, in the form of dividend payments. In Equity Bancshares's case, that would currently equate to about $0.24 per share.
While Equity Bancshares's payout ratio might seem low, this can signify that Equity Bancshares is investing more in its future growth.
Equity Bancshares's most recent dividend payout was on 13 April 2022. The latest dividend was paid out to all shareholders who bought their shares by 28 June 2022 (the "ex-dividend date").
Over the last 12 months, Equity Bancshares's shares have ranged in value from as little as $27.7389 up to $35.7317. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Equity Bancshares's is 0.7028. This would suggest that Equity Bancshares's shares are less volatile than average (for this exchange).
Equity Bancshares, Inc. operates as the bank holding company for Equity Bank that provides a range of banking, mortgage banking, and financial services to individual and corporate customers. The company accepts various demand, savings, money market, and time deposits. Its loan products include commercial and industrial, commercial real estate-backed, commercial lines of credit, working capital, term, equipment financing, acquisition, expansion and development, borrowing base, real estate construction, homebuilder, agricultural, government guaranteed, and other loan products to national and regional companies, restaurant franchisees, hoteliers, real estate developers, manufacturing and industrial companies, agribusiness companies, and other businesses. The company's loan products also comprise various consumer loans to individuals and professionals, including residential real estate loans, home equity loans and lines of credit, installment loans, unsecured and secured personal lines of credit, overdraft protection, and letters of credit. It also provides debit cards; online banking solutions, such as access to account balances, online transfers, online bill payment, and electronic delivery of customer statements; mobile banking solutions comprising remote check deposits with mobile bill pay; ATMs; and treasury management, wire transfer, automated clearing house, and stop payment services. In addition, the company offers cash management deposit products, such as lockbox, remote deposit capture, positive pay, reverse positive pay, account reconciliation services, zero balance accounts, and sweep accounts, as well as banking services through telephone, mail, and personal appointments.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.